
Newsroom
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution
EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions
EssilorLuxottica introduces SWITCH: Vision Innovation Summit by EssilorLuxottica, a visionary showcase for the future of connected healthcare
Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States

The EssilorLuxottica Annual Report 2024 highlights the Group’s significant successes and achievements, with key information about its strategy, Mission, innovation and global footprint.

Explore the world of EssilorLuxottica through official images and videos.
Here you will find the main media contacts of EssilorLuxottica to be used only for corporate, media and public relations matters.

